Tele-health Home Monitoring
DeviceDaily tele-health monitoring data will be collected from randomized participants.
Other names: Home Monitoring
NCT Number: NCT01155050
This study will assess the effect of in-home tele-health monitoring on health outcomes for LSUHCSD chronic disease, overweight or obese patients diagnosed with type II diabetes or hypertension.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Earl K. Long Medical Center, Baton Rouge, Louisiana, United States
This study will assess the effect of in-home tele-health monitoring on health outcomes for LSUHCSD chronic disease, overweight or obese patients diagnosed with type II diabetes or hypertension. Primary emphasis will be on assessing the effect of tele-health home monitoring combined with motivational telephone coaching on weight loss and waist circumference as compared to self-directed, home monitoring alone, and telephone coaching alone. Secondary outcomes such as blood pressure, Hemoglobin A1c (HbA1c), fasting blood sugar, and cholesterol will be examined as well.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily tele-health monitoring data will be collected from randomized participants.
Other names: Home Monitoring
Weekly or bi-weekly phone calls from TrestleTree health coaches with a focus on weight loss.
Other names: Telephone Coaching
Daily collection of data through the tele-health home monitor and weekly or bi-weekly phone calls with a Trestletree Health Coach.
Other names: Home Monitoring and telephone coaching
Time frame: five-month follow-up compared to baseline
Body weight at five-month follow-up minus baseline body weight. Body weight is measured in pounds
Time frame: five-month follow-up compared to baseline
Waist circumference at five-month follow-up minus waist circumference at baseline. Waist circumference is measured in centimeters.
Time frame: Systolic blood pressure (mmHg) at five months minus systolic blood pressure at baseline.
Change is systolic blood pressure (mmHg) from baseline to five-month follow-up.
Time frame: Diastolic blood pressure (mmHg) at five months minus diastolic blood pressure at baseline.
Change in diastolic blood pressure (mmHg) from baseline to follow-up.
Time frame: five months
Change in HbA1c value from baseline to five-month follow-up among those completing the study through five months.
Time frame: five months
Change from baseline to five month follow-up in triglyceride level.
Time frame: five months
Change in total cholesterol level from baseline to five-month follow-up.
Time frame: five months
Change from baseline to five-month follow-up in fasting plasma glucose level.
Pennington Biomedical Research Center
Other
Louisiana State University Health Care Services Division (LSUHCSD) Tele-Health Projects: Weight Loss in Chronic Disease Patient Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05144737
Body Weight, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT03661177
Body Weight, Cardiovascular Diseases
Laramie, Wyoming, United States
View Trial DetailsNCT03543644
Body Weight, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT01630980
Body Weight, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial Details